Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > New Nano Vaccine Fights Leishmaniasis

Abstract:
Iranian researchers at the Pharmaceutical School of Tabriz University of Medical Sciences, in cooperation with their colleagues from Shiraz University of Medical Sciences and Exir Pharmaceutical Company, succeeded in designing a nano vaccine in order to prevent leishmaniasis disease.

New Nano Vaccine Fights Leishmaniasis

Tehran, Iran | Posted on August 23rd, 2011

"The purpose of the present study was to design a nano vaccine against leishmaniasis diseases that exists in three forms of dermal, mucous, and visceral," Dr. Mohammad Ali Danesh, one of the researchers of the project, said.

"Leishmaniasis is a long-term therapy parasitic disease. According to WHO prediction, approximately 12 million people all over the world suffer from leishmaniasis of which 60 thousand die every year," he continued.

Elaborating on the results of the study, the researcher said, "Results indicate that chitosan is able to increase the immunogenicity of superoxide dismutase B1 (SODB1). This is done via increasing the size of the antigen for the better stimulation of the immune system and also via the role of the adjuvant (chitosan). The single and triple dose injections of nanoparticles containing SODB1 show a similar result in the cellular immunological stimulation, which is higher than other groups."

The results make possible the production of a single-dose nano vaccine for Leishmaniasis and the similar protozoal infections due to the similarity of SODB1 in protozoan parasites.

According to Dr. Danesh, no effective vaccine has so far been confirmed against Leishmaniasis, and the present research creates new hopes in this regard.

He said that the next step in their research would be the continuation of studies on animals and the use of other adjuvant in addition to chitosan and measuring the other cellular immunological indices.

"It takes any new vaccine at least 12 years to come to the market, and it must undergo various tests on animals and humans at different stages, and it must be approved by one of the international organizations," Dr. Danesh explained.

####

For more information, please click here

Copyright © Fars News Agency

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Information storage with a nanoscale twist: Discovery of a novel rotational force inside magnetic vortices makes it easier to design ultrahigh capacity disk drives March 28th, 2017

ATTOPSEMI Technology Joins FDXcelerator Program to Deliver Advanced Non-Volatile Memory IP to GLOBALFOUNDRIES 22 FDX Technology Platform: Leading-edge I-fuse brings higher reliability, smaller cell size and ease of programmability for consumer, automotive, and IoT applications March 27th, 2017

Leti and HORIBA Scientific to Host Webinar on Ultrafast Characterization Tool: Plasma Profiling Time-of-Flight Mass Spectrometer Tool Cuts Optimization Time In Layer Deposition and Fabrication of Wide Range of Applications March 27th, 2017

Laser activated gold pyramids could deliver drugs, DNA into cells without harm: Microstructures create temporary pores in cells March 27th, 2017

Nanomedicine

Laser activated gold pyramids could deliver drugs, DNA into cells without harm: Microstructures create temporary pores in cells March 27th, 2017

Researchers make flexible glass for tiny medical devices: Glass can bend over and over again on a nanoscale March 27th, 2017

Cryo-electron microscopy achieves unprecedented resolution using new computational methods March 25th, 2017

Nanobiotix: The Independent Data Monitoring Committee Recommends the Continuation of the Ongoing Phase II/III Trial of NBTXR3 in Soft Tissue Sarcoma March 23rd, 2017

Announcements

Information storage with a nanoscale twist: Discovery of a novel rotational force inside magnetic vortices makes it easier to design ultrahigh capacity disk drives March 28th, 2017

ATTOPSEMI Technology Joins FDXcelerator Program to Deliver Advanced Non-Volatile Memory IP to GLOBALFOUNDRIES 22 FDX Technology Platform: Leading-edge I-fuse brings higher reliability, smaller cell size and ease of programmability for consumer, automotive, and IoT applications March 27th, 2017

Leti and HORIBA Scientific to Host Webinar on Ultrafast Characterization Tool: Plasma Profiling Time-of-Flight Mass Spectrometer Tool Cuts Optimization Time In Layer Deposition and Fabrication of Wide Range of Applications March 27th, 2017

Laser activated gold pyramids could deliver drugs, DNA into cells without harm: Microstructures create temporary pores in cells March 27th, 2017

Research partnerships

A big leap toward tinier lines: Self-assembly technique could lead to long-awaited, simple method for making smaller microchip patterns March 27th, 2017

ATTOPSEMI Technology Joins FDXcelerator Program to Deliver Advanced Non-Volatile Memory IP to GLOBALFOUNDRIES 22 FDX Technology Platform: Leading-edge I-fuse brings higher reliability, smaller cell size and ease of programmability for consumer, automotive, and IoT applications March 27th, 2017

Leti and HORIBA Scientific to Host Webinar on Ultrafast Characterization Tool: Plasma Profiling Time-of-Flight Mass Spectrometer Tool Cuts Optimization Time In Layer Deposition and Fabrication of Wide Range of Applications March 27th, 2017

Cryo-electron microscopy achieves unprecedented resolution using new computational methods March 25th, 2017

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project